News for 'Dr Reddy'

Sensex tanks 630 points; land, tax reform worries hurt sentiment

Sensex tanks 630 points; land, tax reform worries hurt sentiment

Rediff.com12 May 2015

Markets closed in the red on domestic worries.

Covid drug sales shine even as market slows

Covid drug sales shine even as market slows

Rediff.com18 Aug 2020

Fabiflu sales have grown by 62 per cent in July. It was launched in June. This drug is being used by doctors for mild-to-moderate Covid patients even if they are in home isolation.

Meeting 1.35 bn vax dose target in Aug-Dec a long haul

Meeting 1.35 bn vax dose target in Aug-Dec a long haul

Rediff.com6 Aug 2021

While Covishield supplies would meet the target of 500 mn doses between August and December, it looks like Covaxin would miss the target of 400 mn unless the partner sites of Bharat Biotech ramp up very rapidly, reports Sohini Das.

Why 60% of large-cap schemes underperformed the Nifty100 index in CY20

Why 60% of large-cap schemes underperformed the Nifty100 index in CY20

Rediff.com4 Jan 2021

Polarisation and the increase in index weight of a few a stocks have weighed on performance. The worst performers include Nippon India Large Cap and HDFC Top 100 (2.6 per cent).

First-time investor: 'I can afford only low-price stocks'

First-time investor: 'I can afford only low-price stocks'

Rediff.com12 Jan 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Cipla to price Remdesivir for Covid-19 under Rs 5,000

Cipla to price Remdesivir for Covid-19 under Rs 5,000

Rediff.com25 Jun 2020

Hetero has priced the injectable drug at Rs 5,400 per 100 mg vial. With More drugmakers in line to launch the drug soon, the prices may see a further erosion.

Sensex, Nifty end at fresh highs for 2nd straight session

Sensex, Nifty end at fresh highs for 2nd straight session

Rediff.com5 Jun 2017

TCS, Bajaj Auto, Adani Ports and Cipla were the top gainers on BSE Sensex while Coal India, GAIL, Dr Reddy's and Infosys lost the most on the index.

India's first mRNA vaccine gets nod for human trials

India's first mRNA vaccine gets nod for human trials

Rediff.com12 Dec 2020

The novel mRNA vaccine candidate, HGCO19, is supported with seed grant under the Ind-CEPI mission of the Department of Biotechnology. The mRNA vaccines do not use the conventional model to produce immune response. Instead, they carry molecular instructions to make the protein in the body through a synthetic RNA of the virus.

V G Somani: The head of DCGI known as man of actions, not of words

V G Somani: The head of DCGI known as man of actions, not of words

Rediff.com18 Jan 2021

'Safety is my first priority.' 'I need to ensure that any drug or vaccine that our citizens get is first safe.'

Sensex advances for sixth day, IT the bright spot

Sensex advances for sixth day, IT the bright spot

Rediff.com23 Nov 2017

The 50-share NSE Nifty after moving between 10,374.30 and 10,307.30 settled flat at 10,348.75, up 6.45 points, or 0.06 per cent.

Navy successfully test-fires anti-ship missile

Navy successfully test-fires anti-ship missile

Rediff.com18 May 2022

This firing is a significant step towards achieving self-reliance in niche missile technology. Navy said.

'Pralay', India's new-generation missile, test-fired again

'Pralay', India's new-generation missile, test-fired again

Rediff.com23 Dec 2021

'In today's launch, the 'Pralay' missile was tested for heavier payload and different range to prove the precision and lethality of the weapon'

Markets clock highest gain since Oct on US Fed stance

Markets clock highest gain since Oct on US Fed stance

Rediff.com19 Nov 2015

Indian equity markets registered their highest single-day percentage gains since early October.

Delhi likely to get Sputnik V in June: Kejriwal

Delhi likely to get Sputnik V in June: Kejriwal

Rediff.com31 May 2021

"Sputnik will probably offer vaccines after June 20. They will start the vaccine production from the month of August. They are importing the vaccines right now, and they will allot a section of their imported vaccines to the Delhi government," he said.

India successfully test-fires BrahMos supersonic missile from Sukhoi

India successfully test-fires BrahMos supersonic missile from Sukhoi

Rediff.com8 Dec 2021

Describing the mission as a "major milestone" in the development of BrahMos, the sources said that the air version of the missile was test-fired from supersonic fighter aircraft Sukhoi 30 MK-I at 10.30 am.

Sensex, Nifty log gains, break 2-day slide

Sensex, Nifty log gains, break 2-day slide

Rediff.com4 Aug 2017

Results of some blue-chip companies exceeded expectations, providing additional thrust, traders said.

Jagan cancels move to rename Abdul Kalam award

Jagan cancels move to rename Abdul Kalam award

Rediff.com6 Nov 2019

Soon after the above government order was released, the Opposition strongly condemned the move.

Modi's ministers' average age is now 58, down from 61

Modi's ministers' average age is now 58, down from 61

Rediff.com7 Jul 2021

The average age of the new Union council of ministers has reduced to 58 years from 61 years previously following Wednesday's reshuffle.

Anti-Covid drug developed by DRDO cleared for emergency use

Anti-Covid drug developed by DRDO cleared for emergency use

Rediff.com8 May 2021

It said clinical trials of the drug 2-deoxy-D-glucose (2-DG) showed that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.

Share of family-owned firms in total market capitalisation rises to 64.5%

Share of family-owned firms in total market capitalisation rises to 64.5%

Rediff.com4 Jan 2021

The growth was led by family-owned companies and business groups with presence in pharmaceuticals, information technology services, and consumer products.

Markets begin 2021 with a bang; Nifty closes above 14k

Markets begin 2021 with a bang; Nifty closes above 14k

Rediff.com1 Jan 2021

Among major Sensex gainers, ITC rose the most by 2.32 per cent, followed by TCS, M&M, SBI and Bharti Airtel.

Govt approves 2 new vaccines, Covid drug for emergency use

Govt approves 2 new vaccines, Covid drug for emergency use

Rediff.com28 Dec 2021

The announcement comes a day after the Subject Expert Committee (SEC) on COVID-19 of the CDSCO recommended granting emergency use authorisation (EUA) to the COVID-19 vaccines Covovax and Corbevax with certain conditions.

Sensex ends 184 points higher led by IT; Infosys up 5%

Sensex ends 184 points higher led by IT; Infosys up 5%

Rediff.com9 Jan 2015

Infosys, TCS, HUL and Reliance Industries were the top gainers of the day.

Sensex, Nifty stay afloat in volatile trade

Sensex, Nifty stay afloat in volatile trade

Rediff.com20 Nov 2017

The NSE 50-share after moving between 10,309.85 and 10,261.50 on alternate bouts of selling and buying, finished at 10,298.75, with paltry gains of 15.15 points, or 0.15 per cent.

1 cr frontline healthcare workers identified to get Covid vaccine

1 cr frontline healthcare workers identified to get Covid vaccine

Rediff.com24 Nov 2020

Five vaccine candidates are in advanced stages of development in India, out of which four are in Phase II/III and one is in Phase-I/II trials.

'Omicron produces less severe illness'

'Omicron produces less severe illness'

Rediff.com9 Dec 2021

'What prevents infection are masks, physical distancing and good ventilation.'

Why Covid Cases Are Rising

Why Covid Cases Are Rising

Rediff.com8 Jun 2022

'Since many people are vaccinated, this virus is now concentrating on the throat and the nose and replicating fast and transmitting also very fast.' 'That's because the current vaccines will not be able to fight it when it is in the throat, nose or the mouth.'

Coal scam: 'CBI is incapable of finding the truth'

Coal scam: 'CBI is incapable of finding the truth'

Rediff.com13 Jul 2017

'Officers have been made the scapegoat for political failure.' 'No effort has been made to find out who scuttled the prime minister's decision to introduce competitive bidding and why and at whose instance.'

Pharma in 2014: Deals worth billions and fines worth millions

Pharma in 2014: Deals worth billions and fines worth millions

Rediff.com26 Dec 2014

In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.

Microsoft to work with T-Hub to develop startups: Nadell

Microsoft to work with T-Hub to develop startups: Nadell

Rediff.com28 Dec 2015

Nadella advised the start-up community to learn from the failures

Sensex closes flat on special trading day

Sensex closes flat on special trading day

Rediff.com22 Mar 2014

In a range-bound trading, the BSE benchmark Sensex ended a shade higher by 1.57 points in the special 90-minute trading today as funds refrained from making any major commitments in the absence of global cues.

Investors richer by over Rs 6.34 lakh cr as markets cheer Budget

Investors richer by over Rs 6.34 lakh cr as markets cheer Budget

Rediff.com1 Feb 2021

Investors became richer by over Rs 6.34 lakh crore on Monday as markets gave a big shout-out to the Budget 2021-22, which analysts termed as 'unprecedented' against the backdrop of the pandemic-induced slowdown. Cheering the Budget proposals, the BSE benchmark Sensex zoomed 2,314.84 points or 5 per cent to close at 48,600.61. During the day, it jumped 2,478.63 points to 48,764.40. This was the best Budget-day gain for the markets since 1997, analysts said. Following the extremely positive market sentiment, the market capitalisation of BSE-listed companies rallied Rs 6,34,069.67 crore to Rs 1,92,46,713.70 crore.

How life has changed for India's pharma salesforce

How life has changed for India's pharma salesforce

Rediff.com11 May 2020

Pharma companies gear up for the 'new normal' as they train and align their sales forces for a paradigm shift. GSK leads the charge with staggered return-to-work, others plans yoga sessions and health care webinars for salesperson's family.

India successfully tests Abhyas high-speed expendable aerial target

India successfully tests Abhyas high-speed expendable aerial target

Rediff.com22 Oct 2021

The vehicle can be used as an aerial target for evaluation of various missile systems.

ASK AJIT: 'Suffering huge losses in stock market. Please help'

ASK AJIT: 'Suffering huge losses in stock market. Please help'

Rediff.com24 Dec 2021

Ajit Mishra, vice president, research, Religare Broking, answers your queries.

Sensex plunges 1,190 pts; its lowest in 4 months

Sensex plunges 1,190 pts; its lowest in 4 months

Rediff.com20 Dec 2021

Tata Steel was the top loser in the Sensex pack, sinking over 5 per cent, followed by SBI, IndusInd Bank, Bajaj Finance, HDFC Bank and NTPC. NSE Nifty tanked 371 points to 16,614.20.

Markets end higher on rate-cut hopes; RBI policy eyed

Markets end higher on rate-cut hopes; RBI policy eyed

Rediff.com3 Aug 2015

On the sectoral front, rate-sensitive sectors such as Bankex and Auto gained by 1% and 0.7% respectively while BSE Consumer Durables gained 1.4%.

Mayhem! Investors lose Rs 2 trillion as markets go into a tailspin

Mayhem! Investors lose Rs 2 trillion as markets go into a tailspin

Rediff.com12 May 2015

Investors lost Rs 2 trillion as Sensex crashed on Tuesday.

ASK AJIT: Will these shares make me rich?

ASK AJIT: Will these shares make me rich?

Rediff.com30 Dec 2021

Ajit Mishra, vice president, research, Religare Broking, answers your stockmarket queries.

Greece impact: India Inc stares at weakening euro

Greece impact: India Inc stares at weakening euro

Rediff.com30 Jun 2015

Motherson Sumi, Tata Steel, Jaguar Land Rover will face higher cost.